Abstract:Medical Decision Making, Ahead of Print. IntroductionInformation disclosures are used in medicine to provide patients with relevant information. This research examines whether patients are less likely to discuss medical conditions with their physicians after seeing an insurance information disclosure.MethodsThree experimental studies with nonprobability online samples (ntotal = 875 US adult participants) examined the impact of information disclosures on patients' likelihood of disclosing symptoms to providers, using new symptoms and preexisting chronic conditions. The effects of insurance disclosures were also compared to those of pharmaceutical discount disclosures.ResultsThese studies demonstrate that information disclosures can result in unintended consequences for patients and providers. Results showed that information disclosures about insurance claims significantly negatively affected willingness to discuss health information with providers. This effect was consistent for both new health concerns, b = −0.661, P < 0.001 (study 1, n = 250) and b = −0.893, P < 0.001 (study 3, n = 375), as well as chronic conditions, b = −1.175, P < .001 (study 2, n = 250); all studies were conducted in January 2023. Information provided to patients about pharmaceutical savings did not similarly affect willingness to discuss symptoms with providers.LimitationsThese were experimental studies with hypothetical scenarios. Future research is needed to understand how patients react to information disclosures in a physician's office. Future research is also needed to examine the role of specific wording and tone used in information disclosures.ConclusionsPrior research has shown that patients prefer more information and to be involved in their medical decisions; however, these studies demonstrate that some information disclosures can discourage full communication between patients and physicians.ImplicationsThis research has important implications for the potential consequences of information disclosures in health care settings. Information disclosures should be presented in a way that will not discourage candid discussions of patient symptoms.HighlightsThis research found that information disclosures about insurance claims can negatively affect patient willingness to discuss health information with providers.Information disclosures may sometimes fall short of their intended purpose of aiding patient decisions with the goal of improved well-being.When information disclosures are focused on warning about potential new costs, patients may feel uncomfortable discussing new symptoms with their providers.Findings suggest patients may often be more concerned with costs than with addressing their ongoing health problems.

Addressing low-value insurance products with improved consumer information: the case of ancillary health products

Disclosure in insurance law: a comparative analysis

Limitations of german insurance disclosures to improve consumer understanding, with lessons for U.S. insurance practices

How can we improve the customers’ experience of our life products?

More options, more problems? Lost in the health insurance maze

Consumers' Perceptions And Choices Related To Three Value-Based Insurance Design Approaches

Price Transparency in United States' Health Care: A Narrative Policy Review of the Current State and Way Forward

Addressing the Marketing Practices of Medicare Advantage Plans

Endogenous Information and Simplifying Insurance Choice

Wide State-Level Variation In Commercial Health Care Prices Suggests Uneven Impact Of Price Regulation

How Much Information Is Too Much? An Experimental Examination of How Information Disclosures May Unintentionally Encourage the Withholding of Health Information

Balance Billing by Health Care Providers: Assessing Consumer Protections Across States

Effective Disclosures in Financial Decisionmaking

Advantageous Effects of Regulatory Adverse Selection in the Life Insurance Market

Insurance Literacy in Australia: Not Knowing the Value of Personal Insurance

Optimal Mandates and The Welfare Cost of Asymmetric Information: Evidence from The U.K. Annuity Market

CONSUMER BEHAVIOUR AND DECISION MAKING IN HEALTHCARE PURCHASES

Where Ignorance is Bliss: the “dark Corner” of Risk Classification

Scope and Incentives for Risk Selection in Health Insurance Markets With Regulated Competition: A Conceptual Framework and International Comparison

Demand heterogeneity in insurance markets: Implications for equity and efficiency

High-risk pooling for mitigating risk selection incentives in health insurance markets with sophisticated risk equalization: an application based on health survey information